Answer
Faricimab (Vabysmo) is not recommended during breastfeeding because infant risk cannot be excluded; whether to stop breastfeeding or discontinue/avoid treatment must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Vabysmo 120 mg/mL solution for injectionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked